Tessa Bertozzi

Title: Tessa Bertozzi: Innovator in Epigenetic Modifications

Introduction

Tessa Bertozzi is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of epigenetic modifications. With a total of 2 patents, her work is paving the way for advancements in gene therapy and treatment methodologies.

Latest Patents

Tessa's latest patents focus on compositions and methods for making epigenetic modifications. The disclosures provide, in various embodiments, fusion proteins comprising a DNA-binding domain, a DNMT3A-binding domain, and a H3K4me0. Additionally, the patents include polynucleotides and vectors encoding one or more of the fusion proteins. The disclosures also encompass gene-delivery systems, cells, compositions (e.g., pharmaceutical compositions), and kits comprising one or more of the fusion proteins, polynucleotides, or vectors. Furthermore, the methods outlined involve epigenetically modifying a genomic locus in a cell and treating a subject (e.g., a human) in need thereof.

Career Highlights

Tessa Bertozzi is affiliated with the Whitehead Institute for Biomedical Research, where she conducts her innovative research. Her work has garnered attention for its potential applications in therapeutic settings, particularly in the treatment of genetic disorders.

Collaborations

Tessa collaborates with esteemed colleagues, including Edwin Neumann and Jonathan Weissman. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Tessa Bertozzi is a trailblazer in the field of epigenetic modifications, with her patents reflecting her innovative spirit and dedication to biomedical research. Her contributions are expected to have a lasting impact on the future of gene therapy and treatment options.